A Change in Vaccine Efficacy and Duration of Protection Explains Recent Rises in Pertussis Incidence in the United States

作者: Manoj Gambhir , Thomas A. Clark , Simon Cauchemez , Sara Y. Tartof , David L. Swerdlow

DOI: 10.1371/JOURNAL.PCBI.1004138

关键词:

摘要: Over the past ten years incidence of pertussis in United States (U.S.) has risen steadily, with 2012 seeing highest case number since 1955. There also been a shift over same time period age group reporting largest cases (aside from infants), adolescents to 7–11 year olds. We use epidemiological modelling and large dataset explain upsurge. investigate several hypotheses for upsurge by fitting suite dynamic models data National Notifiable Disease Surveillance System (NNDSS) between 1990–2009, as well variety sources 1950–1989. find that: best-fitting model is one which vaccine efficacy duration protection acellular (aP) lower than that whole-cell (wP) vaccine, (efficacy first three doses 80% [95% CI: 78%, 82%] versus 90% 87%, 94%]), increasing rate at disease reported NNDSS not sufficient 3) 2010–2012 predicted well. In this study, we all available U.S. surveillance to: 1) fit set mathematical determine best explains these 2) vaccine-related parameter values model. evidence difference two types, wP aP (aP wP). Future refinement presented here will allow an exploration alternative vaccination strategies such different age-spacings, further booster doses, cocooning.

参考文章(43)
S. Stokley, D. Yankey, C. Dorell, L. Markowitz, A. Cohn, National, state, and local area vaccination coverage among adolescents aged 13-17 years - United States, 2009. Morbidity and Mortality Weekly Report. ,vol. 59, pp. 1018- 1023 ,(2010)
Diane M Simpson, Trena M Ezzati-Rice, Elizabeth R Zell, Forty years and four surveys: How does our measuring measure up? American Journal of Preventive Medicine. ,vol. 20, pp. 6- 14 ,(2001) , 10.1016/S0749-3797(01)00286-0
Holly A. Hill, Laurie D. Elam-Evans, David Yankey, James A. Singleton, Maureen Kolasa, National, State, and Selected Local Area Vaccination Coverage Among Children Aged 19-35 Months - United States, 2014. Morbidity and Mortality Weekly Report. ,vol. 64, pp. 889- 896 ,(2015) , 10.15585/MMWR.MM6433A1
Nicholas Wood, Peter McIntyre, Pertussis: review of epidemiology, diagnosis, management and prevention Paediatric Respiratory Reviews. ,vol. 9, pp. 201- 212 ,(2008) , 10.1016/J.PRRV.2008.05.010
Helen J. Wearing, Pejman Rohani, Estimating the Duration of Pertussis Immunity Using Epidemiological Signatures PLoS Pathogens. ,vol. 5, pp. e1000647- ,(2009) , 10.1371/JOURNAL.PPAT.1000647
J. D. Cherry, P. Olin, The Science and Fiction of Pertussis Vaccines Pediatrics. ,vol. 104, pp. 1381- 1383 ,(1999) , 10.1542/PEDS.104.6.1381
Helen E. Quinn, Deepika Mahajan, Linda Hueston, Patricia Campbell, Robert I. Menzies, Gwendolyn L. Gilbert, Peter B. McIntyre, The seroepidemiology of pertussis in NSW: fluctuating immunity profiles related to changes in vaccination schedules New South Wales Public Health Bulletin. ,vol. 22, pp. 224- 229 ,(2011) , 10.1071/NB11023
Joel I. Ward, James D. Cherry, Swei-Ju Chang, Susan Partridge, Hang Lee, John Treanor, David P. Greenberg, Wendy Keitel, Stephen Barenkamp, David I. Bernstein, Robert Edelman, Kathryn Edwards, Efficacy of an acellular pertussis vaccine among adolescents and adults The New England Journal of Medicine. ,vol. 353, pp. 1555- 1563 ,(2005) , 10.1056/NEJMOA050824